莫特利·愚人和马克·谢普特夫通过出售股票,减少了在Vertex制药公司(一家生物技术公司)的股份。 Motley Fool and Mark Sheptoff reduced their stakes in Vertex Pharmaceuticals, a biotech firm, by selling shares.

莫特利愚昧财富管理公司和马克·谢普托夫金融规划有限公司都削减了在Vertex制药公司持有的股份,该公司是一家生物技术公司,重点研究细胞纤维化疗法。 Motley Fool Wealth Management and Mark Sheptoff Financial Planning LLC both reduced their holdings in Vertex Pharmaceuticals, a biotech company focusing on cystic fibrosis therapies. 莫特利·愚昧公司出售了3 032股股票,将其股份减少了7.7%,而马克·谢普托夫则出售了175股。 Motley Fool sold 3,032 shares, reducing its stake by 7.7%, while Mark Sheptoff sold 175 shares. 另外,Mark Sheptoff还购买了Vertex公司750个股份,该公司是另外一家提供税收技术解决方案的公司,价值约40 000美元。 Separately, Mark Sheptoff also bought 750 shares in Vertex, Inc., a different company that provides tax technology solutions, valued at around $40,000.